Long-term (23 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients
- 1 April 1997
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 26 (4), 871-879
- https://doi.org/10.1016/s0168-8278(97)80255-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Increased plasma levels of glutathione and malondialdehyde after acute ethanol ingestion in humansJournal of Hepatology, 1989
- Lipid peroxidation in acrylonitrile‐treated rats, evidenced by elevated ethane productionJournal of Applied Toxicology, 1989
- Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- Oxygen radicals, lipid peroxidation and the coagulation systemInflammation Research, 1987
- Decreased hepatic glutathione in chronic alcoholic patientsJournal of Hepatology, 1986
- Carbohydrate intolerance associated with reduced hepatic glucose phosphorylating and releasing enzyme activities and peripheral insulin resistance in alcoholics with liver cirrhosisJournal of Hepatology, 1985
- Depressed hepatic glutathione and increased diene conjugates in alcoholic liver diseaseDigestive Diseases and Sciences, 1983
- Alcohol ingestion, liver glutathione and lipoperoxidation: Metabolic interrelations and pathological implicationsLife Sciences, 1982
- Silymarin, an inhibitor of lipoxygenaseCellular and Molecular Life Sciences, 1979
- Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosisDiabetologia, 1979